Skip to main content
Fig. 1 | BMC Cardiovascular Disorders

Fig. 1

From: Impact of thrombus aspiration during ST-Elevation Myocardial Infarction: a six month composite endpoint and risk of stroke analyses of the TASTE trial

Fig. 1

Time to event curves for the primary efficacy quadruple composite endpoint of CV death, cardiogenic shock, new hospitalisation for MI, and new hospitalisation for HF up to 180 days and to maximal follow up. Illustration of the Kaplan-Meier event curves depicting the cumulative probability of the composite endpoint of cardiovascular (CV) death, rehospitalisation for new myocardial infarct (MI), cardiogenic shock or new hospitalisation for heart failure (HF) up to 180 days (Panel a) (Hazard Ratio (HR) 0.93, 95 % CI (0.80-1.09), P = 0.36) or at maximal follow up (mean 25 months) (HR 0.92, 95 % CI (0.82-1.05), P = 0.21) (Panel b) following percutaneous coronary intervention (PCI) with thrombus aspiration (TA) vs. PCI alone

Back to article page